Diphenidine

Diphenidine is a synthetic dissociative of the diarylethylamine class — a structural departure from the arylcyclohexylamine family (ketamine, PCP, DCK) in that it contains two phenyl rings rather than one, connected through an ethylamine chain rather than a cyclohexyl ring. This structural distinction gives diphenidine a qualitatively different pharmacological and experiential character: community members and researchers note that diphenidine produces a more dysphoric, "dark," or unsettling dissociation compared to arylcyclohexylamines, with less of the warmth or euphoria associated with compounds like ketamine or 3-HO-PCP.

Diphenidine acts as an NMDA receptor antagonist, producing dissociation, analgesia, and at higher doses, full dissociative anesthesia. Unlike arylcyclohexylamines, it may have less dopaminergic activity, contributing to a different "flavor" of dissociation. The diarylethylamine class is associated with what community members describe as a colder, more clinical dissociation that can veer into uncomfortable territory at higher doses. Community and anecdotal evidence suggests diphenidine has a distinct toxicity profile from arylcyclohexylamines and that vaporizing diphenidine yields a substantially different and often preferable experience compared to ephenidine, its ethyl-substituted analog.

Diphenidine was widely available during the 2010s research chemical era and generated significant community discussion, including accounts of its use for analgesia in chronic pain contexts.